ZTS Q3 2019 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$52B

Q3 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.6B+7.0% YoY

Gross Profit

$1.1B67.4% margin

Operating Income

$564M35.6% margin

Net Income

$433M27.3% margin

EPS (Diluted)

$0.90

QoQ Revenue Growth

+2.4%

Cash Flow

Operating Cash Flow

$506M

Free Cash Flow

$378M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$11.3B

Total Liabilities

$8.6B

Stockholders' Equity

$2.7B

Cash & Equivalents

$1.8B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.6B	$1.5B	+7.0%
Gross Profit	$1.1B	$975M	+9.4%
Operating Income	$564M	$529M	+6.6%
Net Income	$433M	$347M	+24.8%

Revenue Segments

Horses

$789M51%

Cattle

$389M25%

Swine

$142M9%

Poultry

$135M9%

Dogs and Cats

$45M3%

Fish

$42M3%